Astrazeneca AZN
NYSE AZN
$156.91 -0.77 (-0.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Cash from Operations (2009 - 2026)

Updated

Astrazeneca's Cash from Operations was $4.58 billion in Q2 2026, down 4.1% from $4.77 billion a year earlier but up 5.8% from the prior quarter.

Analysis

Astrazeneca (AZN) Cash from Operations (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Astrazeneca's Cash from Operations was $18.37 billion through Jun 30, 2026, up 3.8% year-over-year; for FY2025, it came in at $18.74 billion, up 17.7% from FY2024.

  • Cash from Operations has now increased for seven consecutive years, with a five-year compound annual growth rate of 21.4% (FY2020 to FY2025).
  • In earlier years, Cash from Operations was $15.92 billion in FY2024 (+15.5%), $13.79 billion in FY2023 (+12.3%), $12.28 billion in FY2022 (+45.7%) and $8.43 billion in FY2021 (+18.8%).
  • Quarterly Cash from Operations has moved between $2.16 billion (Q4 2021) and $6.22 billion (Q3 2025) over five years.
  • Compared with a year earlier, Cash from Operations has declined for three straight quarters, with growth averaging 10.6% over the last six quarters.
  • The best year-over-year quarter for Cash from Operations over five years was Q2 2024 (growth of 52.3%); the worst was Q4 2025 (a decline of 17.3%).
  • Per Business Quant data, AZN's Cash from Operations in the three quarters before Q2 2026 was $4.33 billion (Q1 2026), $3.24 billion (Q4 2025) and $6.22 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.62 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.44 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.58 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.57 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 835.00 Mn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 1.13 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.58 Bn
Mar 31, 2026 4.33 Bn
Dec 31, 2025 3.24 Bn
Sep 30, 2025 6.22 Bn
Jun 30, 2025 4.77 Bn
Mar 31, 2025 4.50 Bn
Dec 31, 2024 3.92 Bn
Sep 30, 2024 4.52 Bn
Jun 30, 2024 4.23 Bn
Mar 31, 2024 3.26 Bn
Jun 30, 2023 2.78 Bn
Mar 31, 2023 3.62 Bn
Jun 30, 2022 2.22 Bn
Mar 31, 2022 3.65 Bn
Dec 31, 2021 2.16 Bn
Sep 30, 2021 2.25 Bn
Jun 30, 2021 1.57 Bn
Mar 31, 2021 2.45 Bn
Dec 31, 2020 2.36 Bn
Sep 30, 2020 2.43 Bn
API Access

Astrazeneca Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=AZN&period=max&api_key=YOUR_API_KEY